Research Article
MicroRNA-552 Accelerates the Progression of Gastric Cancer by Targeting FOXO1 and Regulating PI3K/AKT Pathway
Table 1
Relationship between miR-552 expression and their clinic-pathological characteristics in GC patients.
| Characteristics | Cases | miR-552 | -value | High | Low |
| Age (years) | | | | 0.08 | ≥60 | 38 | 20 | 18 | | <60 | 46 | 30 | 16 | | Gender | | | | 0.15 | Male | 58 | 32 | 26 | | Female | 26 | 18 | 8 | | Tumor size (mm) | | | | 0.21 | ≤5.0 | 31 | 19 | 12 | | >5.0 | 53 | 31 | 22 | | Differentiation | | | | 0.009 | Well/moderate | 24 | 18 | 6 | | Poor | 60 | 32 | 28 | | Lymph node metastasis | | | | 0.04 | Yes | 62 | 42 | 20 | | No | 22 | 8 | 14 | | TNM stage | | | | 0.02 | I-II | 28 | 18 | 10 | | III-IV | 56 | 32 | 24 | |
|
|
Statistical analyses were performed by the χ2 test. was considered significant. |